Home › Free Stock Grades › LNTH
Lantheus Holdings, Inc. (LNTH) Stock Grade
LNTH · Healthcare
A+
Market Cap
$4.5B
P/E Ratio
19.2
Revenue Growth (YoY)
+0.5%
Net Margin
15.2%
Return on Equity
21.4%
Dividend Yield
None
About Lantheus Holdings, Inc.'s fundamentals
Lantheus Holdings is a specialty pharmaceutical manufacturer with a $4.5 billion market capitalization and a P/E ratio of 19.2, indicating moderate valuation relative to earnings. The company maintains a strong net profit margin of 15.2% and generates a robust return on equity of 21.4%, suggesting efficient capital deployment and profitable operations. However, revenue growth has been minimal at just 0.5% year-over-year, pointing to a relatively flat business trajectory. The company does not currently pay a dividend to shareholders.